Showing results (161-170 of 168) with videos related to
Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
The New England Journal of Medicine|September 30, 2025
Sotatercept for Pulmonary Arterial Hypertension within the First Year after DiagnosisVallerie V McLaughlin, Marius M Hoeper, David B Badesch, et al.American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertensionNicholas S Hill, Hunter Gillies, Murali M Chakinala, et al.The New England Journal of Medicine|April 1, 2025
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for DeathMarc Humbert, Vallerie V McLaughlin, David B Badesch, et al.The Lancet. Respiratory Medicine|March 27, 2021
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trialMarius M Hoeper, Hikmet Al-Hiti, Raymond L Benza, et al.Advances in Therapy|August 11, 2025
Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension StudyOlivier Sitbon, Sandeep Sahay, Pilar Escribano Subías, et al.The Lancet. Respiratory Medicine|May 5, 2024
Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trialRobert P Frantz, Vallerie V McLaughlin, Sandeep Sahay, et al.Annals of Internal Medicine|March 25, 2000
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trialD B Badesch, V F Tapson, M D McGoon, et al.American Journal of Respiratory and Critical Care Medicine|April 22, 2017
Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop ReportJohn H Newman, Stuart Rich, Steven H Abman, et al.Pageof 17